Template:Cefuroxime axetil: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 14: | Line 14: | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil contraindications|Contraindications]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil contraindications|Contraindications]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil warnings and precautions|Warnings and Precautions]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil adverse reactions|Adverse Reactions]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil adverse reactions|Adverse Reactions]] | ||
| Line 24: | Line 24: | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil how supplied|How Supplied]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil how supplied|How Supplied]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime clinical | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil clinical studies |Clinical Studies ]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime axetil labels and packages|Labels and Packages]] | ||
|- | |- | ||
|} | |} | ||